Using AI to detect cognitive impairment in older adults
Developing an Artificial Intelligence System to Detect Mild Cognitive Impairment and Alzheimer's Disease Dementia Through Self-Figure Drawing: An Innovative Approach
This study is testing a new AI tool that uses simple drawings to help doctors spot early signs of cognitive problems in older adults, especially those at risk for Alzheimer's disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 4000 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | University of Haifa Academic / other |
| Locations | 1 site (Haifa) |
| Trial ID | NCT05794451 on ClinicalTrials.gov |
What this trial studies
This observational study aims to develop an artificial intelligence system that utilizes self-figure drawings to detect cognitive impairment, particularly in Alzheimer's disease and mild cognitive impairment. The approach leverages convolutional neural networks to analyze these drawings, providing a non-invasive and easily administered tool for early detection. By focusing on adults aged 60 and above with subtle signs of cognitive decline, the study seeks to differentiate between healthy aging and cognitive impairment. The goal is to create a more accessible method for general practitioners to identify at-risk individuals before significant impairment occurs.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 60 and above who show subtle signs of cognitive decline and have at least 10 years of education.
Not a fit: Patients with current or past psychiatric illnesses, severe visual or motor impairments, or terminal illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to earlier and more accurate detection of cognitive impairment, allowing for timely interventions.
How similar studies have performed: While the use of AI in cognitive assessment is a growing field, this specific approach using self-figure drawings is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 60 and above with subtle signs of risk of future cognitive decline, residing in the community or in nursing homes with a minimum of 10 years of education. Exclusion Criteria: * Current or past psychiatric illness, the presence of congenital/organic cognitive condition, severe visual or motor impairment, and terminal illness (to avoid the effect of comorbidities).
Where this trial is running
Haifa
- University of Haifa — Haifa, Israel (Recruiting)
Study contacts
- Principal investigator: Johanna Czamanski-Cohen, PhD — University of Haifa
- Study coordinator: Amit Perry, MA
- Email: peryamit1@gmail.com
- Phone: +9722454258
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.